Radio and PodcastLive Radio & PodcastsScience & Medicine
149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization
149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization - New FDA Approvals
Related Episodes
Continue listening to more episodes from New FDA Approvals.